GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions

With the emergence of various classes of blood glucose-lowering agents, choosing the appropriate drug for each patient is emphasized in diabetes management. Among incretin-based drugs, glucagon-like peptide 1 (GLP-1) receptor agonists are a promising therapeutic option for patients with diabetic kid...

Full description

Saved in:
Bibliographic Details
Main Authors: Ji Hee Yu (Author), So Young Park (Author), Da Young Lee (Author), Nan Hee Kim (Author), Ji A Seo (Author)
Format: Book
Published: The Korean Society of Nephrology, 2022-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!